California State Teachers Retirement System Nymox Pharmaceutical Corp Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.48 $91,082 - $154,714	-62,385 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$2.22 - $3.39 $6,549 - $10,000	2,950 Added 4.96%	62,385 $138,000
Q2 2020 Aug 17, 2020	BUY	$2.1 - $4.6 $124,813 - $273,401	59,435 New	59,435 $211,000
Q2 2019 Aug 14, 2019	SELL	$1.33 - $2.12 $66,208 - $105,535	-49,781 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.29 - $4.06 $9,478 - $11,696	2,881 Added 6.14%	49,781 $164,000
Q3 2017 Nov 13, 2017	BUY	$3.36 - $4.02 $157,584 - $188,537	46,900	46,900 $179,000

Others Institutions Holding NYMX

# of Institutions

Shares Held

150K

Call Options Held

Put Options Held

View Full List

About NYMOX PHARMACEUTICAL CORP

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

More about NYMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account